Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Capital Expenditures (2021 - 2025)

Senti Biosciences has reported Capital Expenditures over the past 5 years, most recently at $26000.0 for Q2 2025.

  • For Q2 2025, Capital Expenditures rose 73.33% year-over-year to $26000.0; the TTM value through Dec 2025 reached $196000.0, up 653.85%, while the annual FY2025 figure was $196000.0, 653.85% up from the prior year.
  • Capital Expenditures for Q2 2025 was $26000.0 at Senti Biosciences, down from $170000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $23.5 million in Q3 2022 and troughed at -$10.2 million in Q3 2023.
  • A 5-year average of $3.3 million and a median of $1.3 million in 2021 define the central range for Capital Expenditures.
  • Biggest five-year swings in Capital Expenditures: soared 3429.32% in 2022 and later plummeted 143.34% in 2023.
  • Year by year, Capital Expenditures stood at $3.3 million in 2021, then skyrocketed by 154.94% to $8.5 million in 2022, then tumbled by 99.86% to $12000.0 in 2023, then fell by 8.33% to $11000.0 in 2024, then surged by 136.36% to $26000.0 in 2025.
  • Business Quant data shows Capital Expenditures for SNTI at $26000.0 in Q2 2025, $170000.0 in Q1 2025, and $11000.0 in Q4 2024.